Price Chart

Profile

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
URL https://www.caratherapeutics.com
Investor Relations URL https://ir.caratherapeutics.com/
HQ State/Province Connecticut
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 04, 2024
Last Earnings Release Nov. 13, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
URL https://www.caratherapeutics.com
Investor Relations URL https://ir.caratherapeutics.com/
HQ State/Province Connecticut
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 04, 2024
Last Earnings Release Nov. 13, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A